Resumen

ABREU DARIAS, Migdel G; CORDERO ESCOBAR, Idoris  y  PEREZ MARTINEZ, Gisela. Reversal of vecuronium-induced neuromuscular blockade: sugammadex vs. neostigmine. Rev cuba anestesiol reanim [online]. 2014, vol.13, n.3, pp. 253-267. ISSN 1726-6718.

Introduction: studies are available about the differences between reversal of neuromuscular blockers with sugammadex and neostigmine. Most studies agree that results are better when sugammadex is used. Objectives: compare the capacity of sugammadex and neostigmine to revert vecuronium-induced neuromuscular blockade. Methods: a case-control study was conducted to evaluate neuromuscular recovery with vecuronium after reversal with sugammadex and neostigmine. Muscular recovery was evaluated by clinical examination. Results: a total 405 patients were studied. Group S was composed of 135 patients and Group N of 270. Mean surgical duration was 32.21±1.2 min for Group S and 33.16 ±1.2 min for Group N. Average reversal time was 2.2 min in Group S and 14.4 min in Group N. The quality of recovery was good in both groups. However, the frequency differences found in patients reverted with sugammadex were statistically significant (p = 0.00001). Complications were more frequent in Group N. Conclusions: the capacity of sugammadex to revert vecuronium-induced neuromuscular blockade was confirmed. Reversal time was 6.54 longer with neostigmine. The quality of recovery was 1.34 times better with sugammadex. Adverse reactions were 11.02 times more frequent with neostigmine than with sugammadex.

Palabras clave : blockade reversal; sugammadex; neostigmine; muscular recovery; quality of reversal.

        · resumen en Español     · texto en Español     · Español ( pdf )